{"slideshow_credits": null, "snippet": "While he appeared a grandfatherly academic, Dr. Sidney Gilman advised a network of Wall Street traders through SAC Capital and eventually crossed the line into criminal behavior.", "abstract": "Colleagues say involvement of Dr Sidney Gilman, noted Alzheimer's researcher, in insider trading investigation of SAC Capital is story of corrupting influence of money; Gilman was drawn into high-rolling life of consultant to financiers about pharmaceuticals and eventually, by his own admission, crossed line into criminal behavior.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Nathaniel", "role": "reported", "lastname": "POPPER", "rank": 1, "organization": ""}, {"firstname": "Bill", "role": "reported", "lastname": "VLASIC", "rank": 2, "organization": ""}], "original": "By NATHANIEL POPPER and BILL VLASIC", "contributor": "Stephanie Steinberg contributed reporting."}, "web_url": "http://www.nytimes.com/2012/12/16/business/sidney-gilmans-shift-led-to-insider-trading-case.html", "lead_paragraph": "While he appeared a grandfatherly academic, Dr. Sidney Gilman advised a network of Wall Street traders through SAC Capital and eventually crossed the line into criminal behavior.", "headline": {"seo": "Sidney Gilman\u2019s Shift Led to Insider Trading Case", "main": "Quiet Doctor, Lavish Insider: A Parallel Life", "print_headline": "Quiet Doctor, Lavish Insider: A Parallel Life"}, "_id": "50ccfe0800315214fbb7f968", "word_count": "1776", "multimedia": [{"height": 126, "url": "images/2012/12/16/us/dog-DOCTOR2/dog-DOCTOR2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2012/12/16/us/dog-DOCTOR2/dog-DOCTOR2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 75, "url": "images/2012/12/16/us/dog-DOCTOR2/dog-DOCTOR2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/12/16/us/dog-DOCTOR2/dog-DOCTOR2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-12-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Gilman, Sidney", "name": "persons", "is_major": "Y", "rank": "2"}, {"value": "SAC Capital Advisors", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Insider Trading", "name": "subject", "is_major": "Y", "rank": "6"}, {"value": "Hedge Funds", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Financial Brokers", "name": "subject", "is_major": "N", "rank": "8"}, {"value": "Alzheimer's Disease", "name": "subject", "is_major": "N", "rank": "9"}, {"value": "Elan Corporation PLC", "name": "organizations", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}